NCT00942851View on ClinicalTrials.gov

A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Focal Dystonia
Interventions
DRUG

Acetyl-Hexapeptide Topical Treatment

AH-8 containing topical treatment

DRUG

placebo

topical treatment NOT containing AH-8

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

BCN Peptides
All Listed Sponsors
collaborator

BCN Peptides

INDUSTRY

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH